Author:
Batool Rabab,Tahir Yousafzai Mohammad,Qureshi Sonia,Ali Miqdad,Sadaf Tahira,Mehmood Junaid,Ashorn Per,Naz Qamar Farah
Funder
Bill and Melinda Gates Foundation
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference26 articles.
1. Theiss-Nyland K, Shakya M et al. Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial. Clinical Infectious Diseases, 2019. 68 (Supplement_2): p. S67-S73.DOI: 10.1093/cid/ciy1106.
2. mondiale de la Santé O, W.H. Organization. Typhoid vaccines: WHO position paper–March 2018–Vaccins antityphoïdiques: note de synthèse de l’OMS–mars 2018. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 2018;93(13): 153-172 [cited Mar 01, 2021]; Available from: https://apps.who.int/iris/handle/10665/272273.
3. Medise BE, Soedjatmiko S et al. Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine. PloS one, 2019;14(2). Available from: https://doi.org/10.1371/journal.pone.0211784.
4. Neuzil KM, Pollard AJ et al. Introduction of typhoid conjugate vaccines in Africa and Asia. Clin Infect Diseases 2019;68(Supplement_1): S27-S30. DOI: 10.1093/cid/ciy878.
5. Theiss-Nyland K, Qadri F et al. Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: a protocol for a phase IIIb trial. Clinical Infectious Diseases, 2019. 68(Supplement_2): p. S74-S82; Available from: https://doi.org/10.1093/cid/ciy1107.DOI: 10.1093/cid/ciy1106.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献